These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7693886)

  • 1. Opioid-glutamate interactions in rat locus coeruleus neurons.
    Oleskevich S; Clements JD; Williams JT
    J Neurophysiol; 1993 Sep; 70(3):931-7. PubMed ID: 7693886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons.
    Martin G; Nie Z; Siggins GR
    J Neurosci; 1997 Jan; 17(1):11-22. PubMed ID: 8987732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mu-opioid receptor selectively potentiates NMDA-induced outward currents in rat locus coeruleus neurons.
    Koyama S; Akaike N
    Neurosci Res; 2008 Jan; 60(1):22-8. PubMed ID: 17976846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid.
    Chen L; Huang LY
    Neuron; 1991 Aug; 7(2):319-26. PubMed ID: 1678615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons.
    Ostermeier AM; Schlösser B; Schwender D; Sutor B
    Anesthesiology; 2000 Oct; 93(4):1053-63. PubMed ID: 11020761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.
    Kow LM; Commons KG; Ogawa S; Pfaff DW
    Brain Res; 2002 May; 935(1-2):87-102. PubMed ID: 12062477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
    Pinnock RD
    Brain Res; 1992 Jun; 583(1-2):237-46. PubMed ID: 1354563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cAMP-dependent protein kinase in mu-opioid modulation of NMDA-mediated synaptic currents.
    Xie CW; Lewis DV
    J Neurophysiol; 1997 Aug; 78(2):759-66. PubMed ID: 9307110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro.
    McFadzean I; Lacey MG; Hill RG; Henderson G
    Neuroscience; 1987 Jan; 20(1):231-9. PubMed ID: 3031541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epileptiform synchronization in the cingulate cortex.
    Panuccio G; Curia G; Colosimo A; Cruccu G; Avoli M
    Epilepsia; 2009 Mar; 50(3):521-36. PubMed ID: 19178556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus.
    Ronken E; Van Muiswinkel FL; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1993 Jan; 230(3):349-55. PubMed ID: 8095023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro.
    Pinnock RD
    Neuroscience; 1992; 47(1):87-94. PubMed ID: 1315940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord.
    Glaum SR; Miller RJ; Hammond DL
    J Neurosci; 1994 Aug; 14(8):4965-71. PubMed ID: 8046463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular mechanisms of opioid tolerance: studies in single brain neurons.
    Christie MJ; Williams JT; North RA
    Mol Pharmacol; 1987 Nov; 32(5):633-8. PubMed ID: 2824980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forskolin enhancement of opioid currents in rat locus coeruleus neurons.
    Osborne PB; Williams JT
    J Neurophysiol; 1996 Sep; 76(3):1559-65. PubMed ID: 8890275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid inhibition in locus coeruleus.
    Travagli RA; Dunwiddie TV; Williams JT
    J Neurophysiol; 1995 Aug; 74(2):519-28. PubMed ID: 7472359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation.
    Marek GJ; Aghajanian GK
    Neuroscience; 1998 Sep; 86(2):485-97. PubMed ID: 9881863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons.
    Zhu W; Pan ZZ
    Neuroscience; 2005; 133(1):97-103. PubMed ID: 15893634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro.
    Chieng B; Christie MJ
    Br J Pharmacol; 1994 Sep; 113(1):121-8. PubMed ID: 7812601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.